Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Sodium cromoglicate
Sanofi-Aventis Ireland Limited T/A SANOFI
S01GX; S01GX01
Sodium cromoglicate
2 percent weight/volume
Eye drops, solution
Product not subject to medical prescription
Other antiallergics; cromoglicic acid
Marketed
2011-05-06
PACKAGE LEAFLET: INFORMATION FOR THE USER 2% W/V EYE DROPS, SOLUTION sodium cromoglicate Is this leaflet hard to see or read? Phone 01 4035600 for help READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. Always use this medicine exactly as described in this leaflet or as your pharmacist has told you. • Keep this leaflet. You may need to read it again • Ask your pharmacist if you need more information or advice • If you get any side effects, talk to your pharmacist or doctor. This includes any side effects not listed in this leaflet. See section 4. • You must talk to a doctor if do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET: 1. What Opticrom Allergy is and what it is used for 2. What you need to know before you use Opticrom Allergy 3. How to use Opticrom Allergy 4. Possible side effects 5. How to store Opticrom Allergy 6. Contents of the pack and other information Opticrom Allergy 2% w/v Eye Drops (called Opticrom Allergy in this leaflet) contain a medicine called sodium cromoglicate. This belongs to a group of medicines called anti-allergics. It works by stopping the release of the natural substances in your eyes that can lead to an allergic reaction. Signs of an allergic reaction include itchy, watery, red or inflamed eyes and puffy eyelids. Opticrom Allergy is used for the relief and treatment of eye allergies. This includes: • Short and long term allergic conjunctivitis (inflammation of parts of the eye) • More severe cases of conjunctivitis (‘vernal kerato conjunctivitis’). Signs include bumps inside the upper eyelid, sensitivity to light and severe itching DO NOT USE OPTICROM ALLERGY IF: • You are allergic (hypersensitive) to sodium cromoglicate, or any of the other ingredients of Opticrom Allergy (listed in Section 6: Contents of the pack and other information) Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat, tongue and w Read the complete document
Health Products Regulatory Authority 09 November 2018 CRN008LGJ Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Opticrom allergy 2% w/v eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium cromoglicate 2.0% w/v. Also contains benzalkonium chloride 0.01% w/v. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution. A clear, colourless to pale yellow, sterile, aqueous solution in a dropper bottle for ocular use. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief and treatment of allergic conjunctivitis and vernal keratoconjunctivitis (vernal or spring catarrh). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION One or two drops into each eye four times daily or as instructed by the physician. Care should be taken to avoid contamination of the contents during use. 4.3 CONTRAINDICATIONS Use in patients sensitive to sodium cromoglicate or any of the ingredients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE As with all ophthalmic preparations containing benzalkonium chloride, patients should be advised not to wear soft contact lenses during treatment with Opticrom Allergy Eye Drops. Health Products Regulatory Authority 09 November 2018 CRN008LGJ Page 2 of 4 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTIONS None known. 4.6 FERTILITY, PREGNANCY AND LACTATION As with all medication, caution should be exercised, especially during the first trimester of pregnancy. Cumulative experience with sodium cromoglicate suggests that it has no adverse effects on foetal development. It should only be used in pregnancy on the advice of a physician and where there is a clear need. It is not known whether sodium cromoglicate is excreted in the breast milk, but on the basis of its physico-chemical properties this is considered unlikely. There is no evidence to suggest that the use of sodium cromoglicate has any undesirable effects on the baby. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES As with all eye drops, instillati Read the complete document